← All organizations
Highest phase reached
Phase 4
First clinical trial
May 4, 2014Last known activity
Mar 1, 2025
Timeline
1960s
- Jan 1, 1965
Helmholtz Centre for Infection Research— Founded
Drugs by trial phase (12 distinct, 11 trials)
Phase 4 (3 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Other trials (5 own, 0 via acquisition)
Indications
Recent trials (13)
- NCT06702345CollaboratorN/AMar 1, 2025
- NCT06452654CollaboratorPhase 4May 8, 2024
- NCT05727267CollaboratorPhase 1Jan 31, 2024
- NCT05353504CollaboratorN/AMar 8, 2022
- NCT04769037Lead sponsorN/AApr 22, 2021
- NCT04769037Reponsible party - principal investigatorN/AApr 22, 2021
- NCT03877601CollaboratorPhase 2Jul 31, 2019
- NCT03877601Overall official - principal investigatorPhase 2Jul 31, 2019
- NCT03955380CollaboratorPhase 1Dec 12, 2018
- NCT03944460CollaboratorPhase 1Apr 9, 2018
- NCT03364868CollaboratorPhase 2Feb 7, 2018
- NCT02362919Lead sponsorN/AFeb 1, 2015
- NCT03361878CollaboratorPhase 4May 4, 2014
Details
- Founded
- Braunschweig, DE Jan 1, 1965
- Last known activity
- Mar 1, 2025